PR Newswire COLUMBIA, Md., March 3, 2025 National survey conducted in recognition of Colorectal Cancer Month in March. COLUMBIA, Md., March 3, 2025 /PRNewswire/ -- A national survey conducted by MedStar Health to gauge the public's ...
PR Newswire SAN FRANCISCO and SUZHOU, China, March 2, 2025 SAN FRANCISCO and SUZHOU, China, March 2, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, ...
PR Newswire MIAMI, Feb. 28, 2025 MIAMI, Feb. 28, 2025 /PRNewswire/ -- Gov. Ron DeSantis on Friday announced $2 million in funding from the Casey DeSantis Florida Cancer Innovation Fund, to increase patients' access to FIU cancer researcher ...
PR Newswire INDIANAPOLIS, Feb. 28, 2025 The positive opinion is based on results from the Phase 3 BRUIN CLL-321 trial, recently presented at the 2024 American Society of Hematology Annual Meeting BRUIN CLL-321 is the first randomized ...
PR Newswire ROTTERDAM, the Netherlands and SAN DIEGO, Feb. 28, 2025 ROTTERDAM, the Netherlands and SAN DIEGO, Feb. 28, 2025 /PRNewswire/ -- SkylineDx, an innovative diagnostics company specializing in the research and development of ...
PR Newswire DONGGUAN, China, Feb. 28, 2025 DONGGUAN, China, Feb. 28, 2025 /PRNewswire/ -- Fapon Biopharma, a biotech innovator in developing therapeutic antibodies and fusion proteins, is pleased to announce that the U.S. Food and Drug ...
PR Newswire WASHINGTON, Feb. 27, 2025 Advocates Push for Groundbreaking Policy Changes, Backing the PSA for HIM Act and POPCaP Program to Advance Prostate Cancer Research and Save More Lives. WASHINGTON, Feb. 27, 2025 /PRNewswire/ -- The ...
Canada NewsWire OTTAWA, ON, Feb. 26, 2025 OTTAWA, ON, Feb. 26, 2025 /CNW/ - Breast cancer is one of the most common forms of cancer and the second leading cause of cancer-related deaths among women. One in eight women in Canada is expected ...
PR Newswire SAN JOSE, Calif., Feb. 26, 2025 SAN JOSE, Calif., Feb. 26, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today ...
PR Newswire NEW YORK, Feb. 25, 2025 NEW YORK, Feb. 25, 2025 /PRNewswire/ -- Novita Pharmaceuticals, Inc. ("Novita"), a privately held, clinical-stage pharmaceutical company dedicated to developing novel cancer drugs through its proprietary ...
While prostate cancer statistics may seem daunting, advances in detection, treatment, and active surveillance offer patients better outcomes.
Ubiquitin-specific proteases play a critical role in regulating cell death pathways in breast cancer, affecting tumor survival, metastasis, and response to therapy.
New research links metabolism to aggressive breast cancer progression, highlighting the role of insulin resistance and exosomes in worsening outcomes for cancer patients.
Targeted alpha therapy shows promise in treating neuroendocrine tumours, offering hope where beta therapies fall short.
Discover why cancer risk increases with age, exploring genetic changes, weakened immunity, and lifestyle factors affecting elderly and middle-aged individuals.
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2025
Careers